📍 Jeddah, Saudi Arabia    October 2–3, 2026 ✉️ infoigcc2024@gmail.com
3RD EDITION  ·  OCTOBER 2026

International Gastrointestinal Cancer Congress

The first scientific event of its kind in the Kingdom of Saudi Arabia, bringing together a select group of experts, physicians, and researchers from around the world to share the latest advancements in the diagnosis and treatment of gastrointestinal and liver diseases.

📅 October 2–3, 2026
📍 voco Jeddah Gate
🌐 English
IGCC delegates and faculty at a previous edition
31National and International Faculty
7Countries Represented
31National and International Faculty
7Countries
6Specialty Tracks
35+Talks & Debates
CMEAccredited Hours
Watch

See IGCC in Action

A quick look at the congress experience — sessions, exhibitions, and the community behind it.

Dr. Emad S. Aljahdali, President, IGCC
A Message from the President

On behalf of the Scientific and Organizing Committees, it is my privilege to welcome you to the 3rd International Gastrointestinal Cancer Congress, taking place in Jeddah this October.

What began as a modest initiative has grown, in just a few editions, into a gathering that brings together clinicians, researchers, and specialists from across the region and beyond — united by a shared commitment to advancing the diagnosis and treatment of gastrointestinal and liver diseases.

I am deeply grateful to our scientific committee, speakers, and partners, whose generosity of time and expertise has shaped a program we hope reflects the very best our field has to offer. None of this would be possible without them — or without you, our delegates, who give this congress its purpose.

I look forward to welcoming you in Jeddah.

Dr. Emad S. Aljahdali President, IGCC
Delegates in conversation between sessions at IGCC
3rdEdition
About the Congress

The First Scientific Event of Its Kind in the Kingdom of Saudi Arabia

The International Gastrointestinal Cancer Congress (IGCC) brings together a select group of experts, physicians, and researchers from around the world to share the latest advancements in modern medicine in the diagnosis and treatment of gastrointestinal and liver diseases.

IGCC aims to be a pioneering scientific platform that sheds light on current challenges and discusses the latest developments in the field through scientific sessions and interactive workshops presented by global speakers, within a professional environment rich in innovation and knowledge exchange.

  • Faculty from Mayo Clinic, Harvard, Indiana University and leading European centres
  • Six specialty tracks with moderated expert debates
  • CME accreditation applied for
Why Attend

Where Endoscopy Meets Oncology

Structured tracks, live debates, and hands-on techniques from the specialists shaping GI cancer care worldwide.

Expert-Led Sessions

Six organ-specific tracks — esophageal, gastric, hepatobiliary, pancreatic, colorectal, and interventional endoscopy — taught by international faculty.

Moderated Debates

Five live debates on genuinely unresolved questions — ESD vs surgery, watch-and-wait in rectal cancer, ERCP vs EUS-guided drainage, and more.

Global Networking

From coffee breaks to the industry symposium, structured time to build relationships with peers, faculty, and sponsors.

Emerging Technology

AI-assisted detection, magnetically controlled capsule endoscopy, third-space endoscopy, and endoscopic full-thickness resection.

CME Accreditation

CME accreditation has been applied for. Credit details will be confirmed closer to the congress.

International Reach

Faculty joining from the United States, Italy, the United Kingdom, Greece, Turkey, Egypt, and Saudi Arabia.

Leadership

Program Leadership

The architects of IGCC 2026's scientific program.

Dr. Muhammad K. Hasan

Dr. Muhammad K. Hasan

Committee Member

Medical Director of the Center for Interventional Endoscopy (CIE) with extensive expertise in therapeutic endoscopy and GI oncology.

Prof. Michael B. Wallace, MPH

Prof. Michael B. Wallace, MPH

Committee Member

Professor at Mayo Clinic and global leader in AI-assisted endoscopic cancer detection; former Editor-in-Chief of Gastrointestinal Endoscopy.

Prof. Mohammad A. Al-Haddad, MSc

Prof. Mohammad A. Al-Haddad, MSc

Committee Member

Professor of Medicine at Indiana University and expert in pancreatic diseases, advanced endoscopy, and GI cancer prevention.

Dr. Moamen Gabr, MD, MSc, FASGE, FACG, AGAF

Dr. Moamen Gabr, MD, MSc, FASGE, FACG, AGAF

Committee Member

Associate Division Director of Clinical – Digestive Diseases and Director of the Interventional Endoscopy Fellowship at the University of Cincinnati.

View the Full Faculty
Faculty

IGCC Faculty

National and International faculty at IGCC 2026.

Prof. Atlal Abusanad
Prof. Atlal Abusanad
Saudi Arabia
Prof. Mohammad Al-Haddad
Prof. Mohammad Al-Haddad
USA
Prof. Murad M Aljiffry
Prof. Murad M Aljiffry
Saudi Arabia
Prof. Shadi Alkhayyat
Prof. Shadi Alkhayyat
Saudi Arabia
Prof. Essam Bedewy
Prof. Essam Bedewy
Egypt
Prof. Antonio Facciorusso
Prof. Antonio Facciorusso
Italy
Prof. Lorenzo Fuccio
Prof. Lorenzo Fuccio
Italy
Prof. Eyad Gadour
Prof. Eyad Gadour
Saudi Arabia
Prof. Mostafa Ibrahim
Prof. Mostafa Ibrahim
Egypt
Prof. Ioannis S. Papanikolaou
Prof. Ioannis S. Papanikolaou
Greece
Prof. Douglas K. Pleskow
Prof. Douglas K. Pleskow
United States
Prof. Michael B. Wallace
Prof. Michael B. Wallace
USA
Dr. Nawaf Aboalfaraj
Dr. Nawaf Aboalfaraj
Saudi Arabia
Dr. Rakan Abulnaja
Dr. Rakan Abulnaja
Saudi Arabia
Dr. Mohammad Albeshir
Dr. Mohammad Albeshir
Saudi Arabia
Dr. Abdulrahman Alfadda
Dr. Abdulrahman Alfadda
Saudi Arabia
Dr. Ibrahim Abdulaziz Alhafid
Dr. Ibrahim Abdulaziz Alhafid
Saudi Arabia
Dr. Malak Saud D Alharbi
Dr. Malak Saud D Alharbi
Saudi Arabia
Dr. Aymen Almuhaidb
Dr. Aymen Almuhaidb
Saudi Arabia
Dr. Nawaf Alotaibi
Dr. Nawaf Alotaibi
Saudi Arabia
Dr. Ibrahim Balubaid
Dr. Ibrahim Balubaid
Saudi Arabia
Dr. Ivo Boškoski
Dr. Ivo Boškoski
Italy
Dr. Adeeb Elghalayini
Dr. Adeeb Elghalayini
Saudi Arabia
Dr. Moamen Gabr
Dr. Moamen Gabr
USA
Dr. Muhammad K. Hasan
Dr. Muhammad K. Hasan
United States
Dr. Sajjad Mahmoud
Dr. Sajjad Mahmoud
United Kingdom
Dr. Benedetto Mangiavillano
Dr. Benedetto Mangiavillano
Italy
Dr. Feras Ayman Moria
Dr. Feras Ayman Moria
Saudi Arabia
Dr. Almotasembillah Rammal
Dr. Almotasembillah Rammal
Saudi Arabia
Dr. Mandeep S. Sawhney
Dr. Mandeep S. Sawhney
United States
Dr. Hakan Şentürk
Dr. Hakan Şentürk
Turkey
Program

Congress Agenda

October 2–3, 2026 · voco Jeddah Gate — full detailed program available closer to the event.

Accredited CME Hours
08:00 – 08:15 Registration, Badge Collection & Welcome Coffee
08:15 – 08:25 Opening Ceremony — Welcome Addresses & Acknowledgements
Keynote08:25 – 08:45
08:25
Keynote
Immunotherapy in GI Cancers: What We Promised, What Delivered, and What's Next
Session 1 · Esophageal Track08:45 – 10:15
Session Chairs: Chair TBC · Co-Chair TBC
08:45
L1
Barrett's Esophagus: Risk Stratification, Surveillance Protocols, and When to Intervene
09:00
L2
Endoscopic Submucosal Dissection for Early Esophageal Cancer: Patient Selection, Technique & Outcomes
09:15
L3
Esophageal Stenting for Malignant Dysphagia: Practical Techniques, Stent Selection, and Complication Management
09:30
L4
Perioperative Immunotherapy in Resectable Esophageal Cancer: Are Checkpoint Inhibitors Ready to Replace Neoadjuvant Chemoradiotherapy?
09:45
Debate
High-Risk T1b Esophageal Adenocarcinoma After Endoscopic Resection: Surveillance, Surgery, or Adjuvant Therapy?
Proposer: Dr. Moamen Gabr · Opponent: Dr. Feras Ayman Moria
10:05 – 10:15 · Questions & Answers
10:15 – 10:30 Coffee Break & Exhibition Visit
Session 2 · Gastric Track10:30 – 12:00
Session Chairs: Chair TBC · Co-Chair TBC
10:30
L1
Gastric Polyps in Clinical Practice: Which Ones to Biopsy, Which to Remove, and Which to Ignore
11:00
L3
Gastric GISTs: Endoscopic Resection, Surveillance, or Surgery — A Risk-Based Decision Framework
11:15
L4
Perioperative Therapy in Resectable Gastric Cancer: Are We Entering the Immunotherapy Era?
11:50 – 12:00 · Questions & Answers
12:00 – 13:30 Lunch Break & Sponsored Industry Symposium
Session 3 · Hepatobiliary Track — Part 113:30 – 14:40
Session Chairs: Chair TBC · Co-Chair TBC
13:30
L1
HCC Surveillance in Cirrhosis: Ultrasound vs MRI — Who Needs Enhanced Imaging and at What Interval?
13:45
L2
EUS-Guided Liver Biopsy: Current Evidence and Emerging Applications
14:00
L3
Digital Cholangioscopy-Guided Targeted Biopsy in Indeterminate Biliary Strictures: Diagnostic Yield, Technique, and Clinical Decision-Making
14:15
L4
Lumen-Apposing Metal Stents (LAMS) in EUS-Guided Biliary Drainage: Technical Tips, Long-Term Patency, and Managing Dysfunction
14:30 – 14:40 · Questions & Answers
14:40 – 14:55 Coffee Break & Exhibition Visit
Hepatobiliary Track — Part 214:55 – 16:10
Session Chairs: Chair TBC · Co-Chair TBC
14:55
L1
Intraductal Radiofrequency Ablation (RFA) for Unresectable Cholangiocarcinoma: Current Evidence and Impact on Stent Patency
15:10
L2
Biliary Stenting in Malignant Hilar Obstruction: Unilateral vs. Bilateral — Endoscopic Strategy and Outcomes
15:25
L3
Endoscopic Management of Ampullary Neoplasms: When to Resect Endoscopically, When to Refer for Surgery, and How to Follow Up
15:40
L4
Hilar Cholangiocarcinoma Palliation: ERCP vs EUS-Guided Biliary Drainage — Which Should Be Standard of Care?
15:55 – 16:10 · Questions & Answers
End of Day One
08:30 – 09:00 Registration & Morning Coffee
Session 4 · Endoscopy Interventions & Innovations09:00 – 10:00
Session Chairs: Chair TBC · Co-Chair TBC
09:00
L1
The Double Obstruction! EUS-Guided Management of Malignant Biliary and Gastric Outlet Obstruction
09:15
L2
Endoscopic Ultrasound-Guided Tumor Ablation: Radiofrequency, Photodynamic Therapy, and Emerging Modalities
09:30
L3
Endoscopic Full-Thickness Resection with Over-The-Scope Clip: Technique and Expanding Indications in GI Oncology
09:45
L4
Third-Space Endoscopy Beyond POEM: Submucosal Tunneling for GI Tumors and Oncology Applications
10:00 – 10:15 Coffee Break & Exhibition Visit
Session 5 · Colorectal Track10:15 – 11:45
Session Chairs: Chair TBC · Co-Chair TBC
10:15
L1
Positive FIT and Non-Explanatory Colonoscopy: Residual Cancer Risk, Further Investigations, and Re-entry into Screening
10:30
L2
Advanced Endoscopic Imaging for Polyp Characterization: NBI, BLI, and AI-Assisted Real-Time Detection
10:45
L3
Early Colorectal Cancer: EMR, ESD, or Surgery — How Do I Decide?
11:00
L4
Stenting for Malignant Colorectal Obstruction: Bridge to Surgery vs Definitive Palliation — Evidence, Risks, and Decision-Making
11:15
Debate
Watch-and-Wait Strategy After Complete Clinical Response to Chemoradiation in Rectal Cancer: Can Endoscopy Replace Surgery?
Proposer: Dr. Rakan Abulnaja · Opponent: TBC
11:35 – 11:45 · Questions & Answers
11:45 – 13:00 Lunch Break
Session 6 · Pancreatic Track13:00 – 14:30
Session Chairs: Chair TBC · Co-Chair TBC
13:00
L1
Pancreatic Neuroendocrine Tumors: Observe, Ablate, or Resect — A Risk-Stratified Approach to Management
13:15
L2
EUS-Guided Tissue Acquisition in Pancreatic Masses: FNA vs. FNB — Which Needle, Which Protocol, and What the Pathologist Needs
13:30
L3
IPMN and Malignancy Prediction: Imaging Features, Cyst Fluid Biomarkers, and Molecular Markers
13:45
L4
From Incidental Finding to Actionable Decision: A Risk-Based Approach to Pancreatic Cysts Using Current International Guidelines
14:00
Debate
Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer: Proven Benefit or Are We Robbing Patients of Their Surgical Window?
14:20 – 14:30 · Questions & Answers
14:30 – 15:00 Closing Ceremony — Group Photo, Congress Highlights & Farewell
End of Day Two

CME accreditation applied for. All times are approximate and subject to change · Speakers subject to confirmation.

Register to Attend
Venue & Travel

Getting to IGCC 2026

Everything international delegates need to plan the trip to Jeddah.

The Venue

voco Jeddah Gate, an IHG Hotel
Plot No. 16, Al Fayha District, Jeddah

All scientific sessions, workshops, and the industry exhibition are held on site. Complimentary parking is available for guests.

Book direct with IHG →

Arriving by Air

King Abdulaziz International Airport (JED)

Jeddah's international gateway, served by direct flights from Europe, Asia, North America, and across the Middle East. Taxis and ride-hailing are readily available to the venue.

Visas & Entry

Many nationalities are eligible for Saudi Arabia's e-Visa or visa on arrival. Requirements vary by country and change periodically.

Delegates should confirm current requirements well in advance via the official portal.

Saudi Visa Portal →

About Jeddah

Saudi Arabia's Red Sea gateway and gateway city to Makkah, home to the UNESCO-listed Al-Balad historic district.

October offers some of the year's most comfortable weather for visitors.

Delegates are responsible for their own travel and accommodation arrangements. For group booking enquiries, contact infoigcc2024@gmail.com.

Conversations

IGCC Podcast

Candid conversations with leading voices in gastrointestinal and liver cancer care, from our faculty and guests — watch every episode on our YouTube channel.

Partners

Proud to Partner With Leading Industry Sponsors

Join Us in Jeddah — October 2–3, 2026

Secure your place among the region's leading specialists in gastrointestinal and liver medicine at voco Jeddah Gate.

00Days
00Hours
00Minutes
00Seconds
Register Now
IGCC 2026 2–3 October · Jeddah
Register